Veterinary Medicines

HEMOSILATE 125 mg/ml solution for injection

Authorised
  • Etamsylate
Download as PDF

Product identification

Medicine name:
HEMOSILATE 125 mg/ml solution for injection
HEMOSILATE 125 mg/ml SOLUCION INYECTABLE
HEMOSILATE 125 mg/ml oldatos injekció A.U.V.
Active substance:
  • Etamsylate
Target species:
  • Cattle
  • Sheep
  • Goat
  • Pig
  • Horse
  • Dog
  • Cat
Route of administration:
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Etamsylate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Goat
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Pig
      • Meat and offal
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Dog
    • Cat
  • Intramuscular use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Goat
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Pig
      • Meat and offal
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB02BX01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • cardboard box containing 10 vials of 20 ml
  • cardboard box containing 5 vials of 20 ml
  • cardboard box containing 1 vial of 20 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ecuphar Veterinaria S.L.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 4196/X/20 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0281/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download
Spanish (PDF)
Published on: 17/03/2023
Download

Package Leaflet

English (PDF)
Published on: 22/12/2023
Download
Spanish (PDF)
Published on: 17/03/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 17/03/2023
Download

eu-PUAR-esv0281001-dcp-hemosilate-125-mg-ml-solution-for-injection-en.pdf

English (PDF)
Published on: 22/12/2023
Download

es-puar-hemosilate-125-mg-ml-solution-for-injection-es.pdf

Spanish (PDF)
Published on: 17/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."